A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Astrazeneca PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 150,000 shares of AZN stock, worth $9.67 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
150,000
Previous 498,950 69.94%
Holding current value
$9.67 Million
Previous $38.9 Million 69.96%
% of portfolio
0.03%
Previous 0.11%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $20.8 Million - $25.2 Million
311,550 Added 166.25%
498,950 $38.9 Million
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $5.74 Million - $6.54 Million
-94,043 Reduced 33.41%
187,400 $12.7 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $17.4 Million - $19.5 Million
281,443 New
281,443 $19 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $23,000 - $24,941
329 New
329 $23,000
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $177 Million - $230 Million
-3,272,170 Reduced 68.01%
1,539,490 $104 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $151 Million - $385 Million
2,839,681 Added 144.0%
4,811,660 $264 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $37.8 Million - $45.4 Million
638,179 Added 47.85%
1,971,979 $130 Million
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $24.3 Million - $29.2 Million
-435,600 Reduced 24.62%
1,333,800 $88.5 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $36.2 Million - $42.7 Million
-669,688 Reduced 27.46%
1,769,400 $103 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $35.3 Million - $38.6 Million
635,065 Added 35.2%
2,439,088 $146 Million
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $84.7 Million - $105 Million
-1,748,824 Reduced 49.22%
1,804,023 $108 Million
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $32.3 Million - $37.3 Million
-685,451 Reduced 16.17%
3,552,847 $177 Million
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $182 Million - $218 Million
3,753,816 Added 774.81%
4,238,298 $212 Million
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $11.2 Million - $12.9 Million
-210,906 Reduced 30.33%
484,482 $26.6 Million
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $6.26 Million - $8.04 Million
145,339 Added 26.42%
695,388 $36.8 Million
Q1 2020

May 15, 2020

BUY
$37.79 - $51.33 $20.8 Million - $28.2 Million
550,049 New
550,049 $24.6 Million
Q3 2019

Nov 15, 2019

SELL
$40.12 - $45.47 $59.5 Million - $67.4 Million
-1,482,198 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $32.6 Million - $36.5 Million
-875,724 Reduced 37.14%
1,482,198 $61.2 Million
Q1 2019

May 15, 2019

BUY
$35.49 - $43.02 $66.2 Million - $80.2 Million
1,865,364 Added 378.71%
2,357,922 $95.3 Million
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $9.76 Million - $11 Million
-264,842 Reduced 34.97%
492,558 $18.7 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $71.1 Million - $81.2 Million
-2,044,646 Reduced 72.97%
757,400 $30 Million
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $3.58 Million - $3.83 Million
-103,489 Reduced 3.56%
2,802,046 $98.4 Million
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $65.3 Million - $72.5 Million
1,980,335 Added 214.04%
2,905,535 $102 Million
Q4 2017

Feb 14, 2018

SELL
$32.09 - $34.78 $9.62 Million - $10.4 Million
-299,739 Reduced 24.47%
925,200 $32.1 Million
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $35.5 Million - $41.6 Million
1,224,939
1,224,939 $41.5 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.